Cargando…

High Risk of Severe Anaemia after Chlorproguanil-Dapsone+Artesunate Antimalarial Treatment in Patients with G6PD (A-) Deficiency

BACKGROUND: Glucose-6-phosphate dehydrogenase (G6PD) deficiency is the most common inherited human enzyme defect. This deficiency provides some protection from clinical malaria, but it can also cause haemolysis after administration of drugs with oxidant properties. METHODS: The safety of chlorprogua...

Descripción completa

Detalles Bibliográficos
Autores principales:	Fanello, Caterina I., Karema, Corine, Avellino, Pamela, Bancone, Germana, Uwimana, Aline, Lee, Sue J., d'Alessandro, Umberto, Modiano, David
Formato:	Texto
Lenguaje:	English
Publicado:	Public Library of Science 2008
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2603295/ https://www.ncbi.nlm.nih.gov/pubmed/19112496 http://dx.doi.org/10.1371/journal.pone.0004031

Ejemplares similares

An Open Label, Randomised Trial of Artesunate+Amodiaquine, Artesunate+Chlorproguanil-Dapsone and Artemether-Lumefantrine for the Treatment of Uncomplicated Malaria
por: Owusu-Agyei, Seth, et al.
Publicado: (2008)

Glucose-6-phosphate dehydrogenase deficiency, chlorproguanil-dapsone with artesunate and post-treatment haemolysis in African children treated for uncomplicated malaria
por: Van Malderen, Carine, et al.
Publicado: (2012)

Open-Label Comparative Clinical Study of Chlorproguanil−Dapsone Fixed Dose Combination (Lapdap™) Alone or with Three Different Doses of Artesunate for Uncomplicated Plasmodium falciparum Malaria
por: Wootton, Daniel G., et al.
Publicado: (2008)

Chlorproguanil−Dapsone−Artesunate versus Artemether−Lumefantrine: A Randomized, Double-Blind Phase III Trial in African Children and Adolescents with Uncomplicated Plasmodium falciparum Malaria
por: Premji, Zul, et al.
Publicado: (2009)

Randomized Trial of Safety and Effectiveness of Chlorproguanil-Dapsone and Lumefantrine-Artemether for Uncomplicated Malaria in Children in The Gambia
por: Dunyo, Samuel, et al.
Publicado: (2011)

Measurement of adherence, drug concentrations and the effectiveness of artemether-lumefantrine, chlorproguanil-dapsone or sulphadoxine-pyrimethamine in the treatment of uncomplicated malaria in Malawi
por: Bell, David J, et al.
Publicado: (2009)

Dapsone: Haemolysis leading to anaemia: case report
Publicado: (2021)

Risks of Hemolysis in Glucose-6-Phosphate Dehydrogenase Deficient Infants Exposed to Chlorproguanil-Dapsone, Mefloquine and Sulfadoxine-Pyrimethamine as Part of Intermittent Presumptive Treatment of Malaria in Infants
por: Poirot, Eugenie, et al.
Publicado: (2015)

Enhancing the antimalarial activity of artesunate
por: Adebayo, J. O., et al.
Publicado: (2020)

Embryotoxicity and Toxicokinetics of the Antimalarial Artesunate in Rats
por: Chung, Moon-Koo, et al.
Publicado: (2013)

Counterfeit artesunate antimalarials in southeast Asia
por: Newton, Paul N, et al.
Publicado: (2003)

Plasmodium falciparum clearance in clinical studies of artesunate-amodiaquine and comparator treatments in sub-Saharan Africa, 1999–2009
por: Zwang, Julien, et al.
Publicado: (2014)

Dapsone: Methaemoglobinaemia, intravascular haemolysis and acute on chronic anaemia: case report
Publicado: (2021)

Haemoglobin changes and risk of anaemia following treatment for uncomplicated falciparum malaria in sub-Saharan Africa
por: Zwang, Julien, et al.
Publicado: (2017)

Randomized Trial of Artesunate+Amodiaquine, Sulfadoxine-Pyrimethamine+Amodiaquine, Chlorproguanal-Dapsone and SP for Malaria in Pregnancy in Tanzania
por: Mutabingwa, Theonest K., et al.
Publicado: (2009)

Stopping prereferral rectal artesunate — a grave error
por: Watson, James A, et al.
Publicado: (2022)

Kaempferol Addition Increases the Antimalarial Activity of Artesunate in Experimental Mice
por: Ounjaijean, Sakaewan, et al.
Publicado: (2020)

Antimalarial and anticancer properties of artesunate and other artemisinins: current development
por: Khanal, Pitambar
Publicado: (2021)

G6PD Variants and Haemolytic Sensitivity to Primaquine and Other Drugs
por: Bancone, Germana, et al.
Publicado: (2021)

Intermittent preventive antimalarial treatment for children with anaemia
por: Athuman, Mwaka, et al.
Publicado: (2015)

Pharmacokinetic Study of Rectal Artesunate in Children with Severe Malaria in Africa
por: Fanello, Caterina, et al.
Publicado: (2021)

Repurposing antimalarial artesunate for the prophylactic treatment of depression: Evidence from preclinical research
por: Huang, Shihao, et al.
Publicado: (2022)

Repurposing of artesunate, an antimalarial drug, as a potential inhibitor of hepatitis E virus
por: Bhise, Neha, et al.
Publicado: (2023)

Prevalence and Risk Factors of Neonatal Hyperbilirubinemia in a Semi-Rural Area of the Democratic Republic of Congo: A Cohort Study
por: Fanello, Caterina, et al.
Publicado: (2023)

Artesunate versus quinine in the treatment of severe falciparum malaria in African children (AQUAMAT): an open-label, randomised trial
por: Dondorp, Arjen M, et al.
Publicado: (2010)

The Antimalarial Drug Artesunate Mediates Selective Cytotoxicity by Upregulating HO-1 in Melanoma Cells
por: Jochims, Finn, et al.
Publicado: (2023)

No evidence that chloroquine or hydroxychloroquine induce hemolysis in G6PD deficiency()
por: Schilling, William H.K., et al.
Publicado: (2020)

Comparing changes in haematologic parameters occurring in patients included in randomized controlled trials of artesunate-amodiaquine vs single and combination treatments of uncomplicated falciparum in sub-Saharan Africa
por: Zwang, Julien, et al.
Publicado: (2012)

Dapsone in dermatology and beyond
por: Wozel, Gottfried, et al.
Publicado: (2013)

Dapsone-Induced Hypoxia
por: Keerty, Dinesh, et al.
Publicado: (2020)

Dapsone hypersensitivity syndrome
por: Zhao, Qing, et al.
Publicado: (2023)

Impact of protective haemoglobins C and S on P. falciparum malaria transmission in endemic area
por: Gouagna, Louis C, et al.
Publicado: (2010)

Dapsone induced cholangitis as a part of dapsone syndrome: a case report
por: Itha, Srivenu, et al.
Publicado: (2003)

Dapsone hypersensitivity syndrome: A rare life threatening complication of dapsone therapy
por: Vinod, Kolar Vishwanath, et al.
Publicado: (2013)

Primaquine-induced haemolysis in females heterozygous for G6PD deficiency
por: Chu, Cindy S., et al.
Publicado: (2018)

Clinical tolerability of artesunate-amodiaquine versus comparator treatments for uncomplicated falciparum malaria: an individual-patient analysis of eight randomized controlled trials in sub-Saharan Africa
por: Zwang, Julien, et al.
Publicado: (2012)

Pharmacovigilance of antimalarial treatment in Africa: is it possible?
por: Talisuna, Ambrose O, et al.
Publicado: (2006)

Efficacy of artesunate-amodiaquine for treating uncomplicated falciparum malaria in sub-Saharan Africa: a multi-centre analysis
por: Zwang, Julien, et al.
Publicado: (2009)

Computer-aided synthesis of dapsone-phytochemical conjugates against dapsone-resistant Mycobacterium leprae
por: Swain, Shasank S., et al.
Publicado: (2020)

Monitoring the Response of Plasmodium vivax to Chloroquine and Uncomplicated P. falciparum to Artesunate-fansidar Antimalarials in Southeastern Iran
por: AZARIAN MOGHADAM, Hamid, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_trthpf9rpu5qc8prfq6hsslp8p